Drug Product Advancement: A Path Through Development By Powder-In-Capsule Approach

Using micro-dosing technology and powder-in-capsule (PIC) or powder-in-bottle (PIB) approaches, biopharmaceutical companies can increase speed to clinic, quickly assess their candidate compounds, and remain cost-conscious in early stage development.

In a webinar, Lonza experts reviewed best practices PIC and PIB challenges and discussed rapid encapsulation transfer from clinic to commercial scale. To learn more, please access our webinar slides.